# Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma

> **NCT05019976** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Chicago** · enrollment: 30 (actual)

## Conditions studied

- Non-hodgkin Lymphoma
- Hodgkin Lymphoma
- Lymphoma

## Interventions

- **RADIATION:** Radiation - Dose Level 0
- **RADIATION:** Radiation - Dose Level 1
- **RADIATION:** Radiation - Dose Level 2
- **RADIATION:** Radiation - Dose Level 3
- **RADIATION:** Radiation - Dose Level 4

## Key facts

- **NCT ID:** NCT05019976
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-30
- **Primary completion:** 2027-12-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05019976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05019976, "Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05019976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*